menu

MYR Pharmaceuticals — Treatment of HBV & HDV Infections

Career opportunities — Join our team! Privacy Policy

News & Library

HomeNews & Library
HomeNews & Library

Press releases

September 17, 2020 - MYR Pharmaceuticals launches HEPCLUDEX® in Germany, France and Austria. More...

Scientific Publications

MYR Pharma's scientific founders and collaborators have published numerous papers in top peer reviewed journals describing Myrcludex B mechanism of action and the results of preclinical and clinical development. Myrcludex B has been highlighted in many recent review articles as one of the leading drugs for the treatment of HBV and HDV. More...